openPR Logo
Press release

Global OTC Pediatric Healthcare Market Proposals & Trends Leading to 2.1% CAGR Growth during 2017-2022

02-27-2018 01:47 PM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

The scope of Fact.MR’s report is to analyze the global OTC pediatric healthcare market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global OTC pediatric healthcare market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to OTC pediatric healthcare. The report commences with a brief information of the global OTC pediatric healthcare market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global OTC pediatric healthcare market.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=257

According to the latest report by Fact.MR, the global market for OTC pediatric healthcare is anticipated to reach close to US$ 10,000 million revenue by 2022 end. The market is expected to experience sluggish growth during the forecast period, 2017 to 2022. Increasing risk of serious side-effects due to OTC medicines based on self-care decision is restricting the parents from choosing OTC drugs for children, thus leading to the decline in OTC pediatric healthcare.

Forecast Highlights on Global OTC Pediatric Healthcare Market

1- Among all the other regions, North America is anticipated to surpass US$ 2,000 million revenue by the end of 2022. Increasing consumer awareness to treat minor health issues among children due to a various initiative by the government such as campaign, awareness drive, etc., is one of the factors driving the growth of OTC drugs in the region.

2- Japan and the Middle East and Africa (MEA) are expected to be the least growing market in OTC pediatric healthcare during 2017-2022.

3- Dermatology OTC pediatric products are anticipated to reach close to US$ 3,500 million towards the end of 2022. Global sales of Dermatology OTC pediatric products is expected to gain around one-third revenue share on the global revenues by the end of 2017.

4- Sales of OTC pediatric products will be highest through drug stores/ pharmacies. By the end of 2017, drug stores/pharmacies are expected to account for nearly one-third of the revenue share of the global revenues. Meanwhile, sales of OTC pediatric products will be the least through convenience stores.

Browse Full Report With TOC- https://www.factmr.com/report/257/otc-pediatric-healthcare-market

Table of Content

Global OTC Pediatric Healthcare Market - Executive Summary
Global OTC Pediatric Healthcare Market Overview
2.1. Introduction
       2.1.1. Global OTC Pediatric Healthcare Market Taxonomy
       2.1.2. Global OTC Pediatric Healthcare Market Definition
2.2. Global OTC Pediatric Healthcare Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global OTC Pediatric Healthcare Market Y-o-Y Growth
2.3. Global OTC Pediatric Healthcare Market Dynamics
       2.3.1. Drivers
       2.3.2. Restraints
       2.3.3. Trends
2.4. Supply Chain
2.5. Cost Structure
2.6. Pricing Analysis 
2.7. Raw Material Sourcing Strategy and Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region
Global OTC Pediatric Healthcare Market Analysis and Forecast By Product Type 
3.1. Global OTC Pediatric Healthcare Market Size and Forecast By Product Type, 2012-2022
       3.1.1. Gastro Intestinal OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Dermatology OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
       3.1.3. ENT OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region
       3.1.4. Nutrition/Vitamins OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                3.1.4.2. Market Share Comparison, By Region
                3.1.4.3. Y-o-Y growth Comparison, By Region
       3.1.5. Other Products OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
                3.1.5.1. Revenue (US$ Mn) Comparison, By Region
                3.1.5.2. Market Share Comparison, By Region
                3.1.5.3. Y-o-Y growth Comparison, By Region
Continue…..

Request For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=257

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global OTC Pediatric Healthcare Market Proposals & Trends Leading to 2.1% CAGR Growth during 2017-2022 here

News-ID: 959758 • Views:

More Releases from Fact.MR

Body Area Network Market Forecasted to Expand Rapidly, Projecting US$ 229.8 Billion Value by 2032
Body Area Network Market Forecasted to Expand Rapidly, Projecting US$ 229.8 Bill …
It is anticipated that the worldwide body area network market will expand at a strong 22.3% CAGR. Its anticipated value increased from US$ 24.6 billion in 2021 to around US$ 229.8 billion by 2032. A new generation of body-attachable wireless body sensors has emerged in response to advancements in wireless communication technology and various physiological sensor types. Download a Sample Copy Of Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7208 Body Area Networks, or BANs, are becoming a game-changer
Payroll Outsourcing Services Market Is Likely To Be Valued At US$ 32607.5 Million By 2033: Fact.MR Report
Payroll Outsourcing Services Market Is Likely To Be Valued At US$ 32607.5 Millio …
The global payroll outsourcing services market was valued at US$ 17000 Million in 2022. During the 2023-2033 period of assessment, demand is expected to rise at a 6.1% value CAGR, likely to surpass a valuation of US$ 32607.5 Million by the end of the said forecast period. The Payroll Outsourcing Services Industry sales study offers a comprehensive analysis on diverse features including production capacities, Payroll Outsourcing Services demand, product developments, sales
Carotenoids Market Is Forecasted To Reach US$ 2.45 Billion at 5.4% CAGR By 2034: Fact.MR Report
Carotenoids Market Is Forecasted To Reach US$ 2.45 Billion at 5.4% CAGR By 2034: …
With an estimated market size of US$ 1.45 billion in 2024, the global carotenoid market is projected to expand at a CAGR of 5.4% and reach a market value of US$ 2.45 billion by 2034-end. Growth prospects of the market remain optimistic, owing to shifting consumer preferences for natural ingredients, expanding carotenoid applications in a range of industries, and ongoing developments in product development and formulation techniques. The Carotenoid Industry sales
Canned Fruits Market Is Anticipated To Reach A Valuation Of US$ 12 Billion By 2032: Fact.MR Report
Canned Fruits Market Is Anticipated To Reach A Valuation Of US$ 12 Billion By 20 …
The value of the global canned fruits market is US$ 9.8 billion in 2022, which is projected to climb to US$ 12 billion by 2032-end, increasing at a CAGR of 2% through 2032. The Canned Fruits Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Fruits demand, product developments, sales revenue generation and Canned Fruits market outlook across the globe. market research report by Fact.MR, (Leading business

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current